Transient overexpression lysate of integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) (ITGB1), transcript variant 1E
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
LY408839 is the same product as LY430020.
Products
ITGB1 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
ITGB1 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Transient overexpression of ITGB1, transcript variant 1A, in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
Transient overexpression of ITGB1, transcript variant 1E, in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
Transient overexpression of ITGB1, transcript variant 1D, in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
Rabbit Polyclonal Anti-ITGB1 Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
Rabbit Polyclonal Anti-ITGB1 Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
Mouse monoclonal anti-ITGB1 antibody
| Applications | WB |
| Reactivities | Human |
Rabbit Polyclonal Anti-ITGB1 Antibody (Extracellular Domain)
| Applications | IHC |
| Reactivities | Human |
Rabbit Polyclonal Anti-ITGB1 Antibody (Extracellular Domain)
| Applications | IHC |
| Reactivities | Human (Predicted: Bat, Dog, Horse) |
Integrin beta 1 (ITGB1) mouse monoclonal antibody, clone B-D15, Purified
| Applications | FC, IHC |
| Reactivities | Human |
Integrin beta 1 (ITGB1) mouse monoclonal antibody, clone B-D15, Azide Free
| Applications | FC, IHC |
| Reactivities | Human |
Integrin beta 1 (ITGB1) mouse monoclonal antibody, clone B-D15, FITC
| Applications | FC |
| Reactivities | Human |
Rabbit anti CD29 Polyclonal Antibody
| Reactivities | Human |
活动过滤器
优化搜索结果
Species
Reactivities
Antibody Hosts
Expression Hosts
Lentivirus
Vectors
Reporters
Conjugates
Clonalities
Mutants
Brands
QC Levels
Pathways
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (58)
- Axon guidance (58)
- Cell adhesion molecules (CAMs) (58)
- Dilated cardiomyopathy (58)
- ECM-receptor interaction (58)
- Focal adhesion (58)
- Hypertrophic cardiomyopathy (HCM) (58)
- Leukocyte transendothelial migration (58)
- Pathogenic Escherichia coli infection (58)
- Pathways in cancer (58)
- Regulation of actin cytoskeleton (58)
- Small cell lung cancer (58)
